{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T13:15:06Z","timestamp":1779196506084,"version":"3.51.4"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Korea Health Technology R&D Project through the Korea Health Industry Development Institute","award":["HE23C002800"],"award-info":[{"award-number":["HE23C002800"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,30]]},"abstract":"<jats:p>Although both intensive insulin therapy (IIT) and combined oral antidiabetic drugs (COAD) can achieve initial intensive glycemic control, evidence comparing their long-term effectiveness following initial remission remains limited. Therefore, this study aims to compare long-term glycemic control and the risk of drug-free remission failure between IIT and COAD in patients who successfully achieved initial intensive glycemic control. This duplicated target trial utilized a cohort of 60,736 patients with type 2 diabetes from 3 hospitals in South Korea (2001\u20132024). Patients treated with insulin were assigned to the IIT group, and those receiving metformin combined with other oral antidiabetic drugs to the COAD group. Successful initial intensive treatment was defined as HbA1c\u2005&lt;7.0% following treatment cessation. Failure of drug-free glycemic remission was defined as HbA1c\u2005\u22657.0% during follow-up. After 1:1 propensity score matching, Cox proportional hazard model was employed to evaluate the risk of remission failure between groups, estimating adjusted hazard ratios (aHRs) with 95% confidence intervals. Among 2092 patients achieving successful initial intensive treatment, each group assigned 355 following 1:1 propensity score matching (IIT group: mean age, 64.56 [standard deviation, 13.16] years; 49.0% female; COAD group: mean age, 64.08 [standard deviation, 12.90] years; 45.6% female). Baseline mean HbA1c and fasting plasma glucose were 6.26% and 115.4mg\/dL in the IIT group, and 6.31% and 126.4mg\/dL in the COAD group. During follow-up, HbA1c and body weight diverged significantly, with higher levels observed in the COAD group. The IIT group indicated a significant lower risk of drug-free glycemic remission failure compared to the COAD group (aHR, 0.47 [95% confidence interval, 0.31\u20130.73]). In patients with newly diagnosed type 2 diabetes achieving successful initial intensive treatment, IIT was associated with better long-term glycemic control compared with COAD, despite treatment discontinuation.<\/jats:p>","DOI":"10.1097\/md.0000000000047235","type":"journal-article","created":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T17:00:39Z","timestamp":1769965239000},"page":"e47235","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Long-term effectiveness on glycemic control of insulin compared to combined oral antidiabetic drugs for initial intensive treatment in newly diagnosed type 2 diabetes: A duplicated target trial"],"prefix":"10.1097","volume":"105","author":[{"given":"Tae Hyeon","family":"Kim","sequence":"first","affiliation":[{"name":"Center for Digital Health, Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, South Korea"},{"name":"Department of Precision Medicine, Kyung Hee University College of Medicine, Seoul, South Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yerin","family":"Hwang","sequence":"additional","affiliation":[{"name":"Center for Digital Health, Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, South Korea"},{"name":"Department of Medicine, Kyung Hee University College of Medicine, Seoul, South Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selin","family":"Woo","sequence":"additional","affiliation":[{"name":"Center for Digital Health, Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, South Korea"},{"name":"Department of Medicine, Kyung Hee University College of Medicine, Seoul, South Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyeongmin","family":"Lee","sequence":"additional","affiliation":[{"name":"Center for Digital Health, Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, South Korea"},{"name":"Department of Regulatory Science, Kyung Hee University, Seoul, South Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yejun","family":"Son","sequence":"additional","affiliation":[{"name":"Center for Digital Health, Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, South Korea"},{"name":"Department of Precision Medicine, Kyung Hee University College of Medicine, Seoul, South Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seoyoung","family":"Park","sequence":"additional","affiliation":[{"name":"Center for Digital Health, Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, South Korea"},{"name":"Department of Precision Medicine, Kyung Hee University College of Medicine, Seoul, South Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyunjee","family":"Kim","sequence":"additional","affiliation":[{"name":"Center for Digital Health, Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, South Korea"},{"name":"Department of Precision Medicine, Kyung Hee University College of Medicine, Seoul, South Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju-Young","family":"Shin","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Sungkyunkwan University, Suwon, South Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YongHyun","family":"Cho","sequence":"additional","affiliation":[{"name":"RWE Division, Kakao Healthcare Corp., Seongnam, South Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dahye","family":"Shin","sequence":"additional","affiliation":[{"name":"RWE Division, Kakao Healthcare Corp., Seongnam, South Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dosang","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, College of Medicine, Ewha Womans University, Seoul, South Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Jae","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Keimyung University Dongsan Hospital, Daegu, South Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Youl","family":"Rhee","sequence":"additional","affiliation":[{"name":"Center for Digital Health, Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, South Korea"},{"name":"Department of Precision Medicine, Kyung Hee University College of Medicine, Seoul, South Korea"},{"name":"Department of Medicine, Kyung Hee University College of Medicine, Seoul, South Korea"},{"name":"Department of Endocrinology and Metabolism, Kyung Hee University College of Medicine, Seoul, South Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1628-9948","authenticated-orcid":false,"given":"Dong Keon","family":"Yon","sequence":"additional","affiliation":[{"name":"Center for Digital Health, Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, South Korea"},{"name":"Department of Precision Medicine, Kyung Hee University College of Medicine, Seoul, South Korea"},{"name":"Department of Medicine, Kyung Hee University College of Medicine, Seoul, South Korea"},{"name":"Department of Regulatory Science, Kyung Hee University, Seoul, South Korea"},{"name":"Department of Pediatrics, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, South Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260519","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021.","volume":"402","author":"Ong","year":"2023","journal-title":"Lancet"},{"key":"R2-20260519","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4239\/wjd.v14.i3.130","article-title":"Pancreatic \u03b2-cell dysfunction in type 2 diabetes: implications of inflammation and oxidative stress.","volume":"14","author":"Dludla","year":"2023","journal-title":"World J Diabetes"},{"key":"R3-20260519","doi-asserted-by":"crossref","first-page":"368","DOI":"10.4093\/dmj.2020.0046","article-title":"Time to reach target glycosylated hemoglobin is associated with long-term durable glycemic control and risk of diabetic complications in patients with newly diagnosed type 2 diabetes mellitus: a 6-year observational study.","volume":"45","author":"Kim","year":"2021","journal-title":"Diabetes Metab J"},{"key":"R4-20260519","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s12933-023-02026-9","article-title":"Glycemic control, HbA1c variability, and major cardiovascular adverse outcomes in type 2 diabetes patients with elevated cardiovascular risk: insights from the ACCORD study.","volume":"22","author":"Pei","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"R5-20260519","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes.","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"R6-20260519","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2337\/dc15-2283","article-title":"Nine-year effects of 3.7 years of intensive glycemic control on cardiovascular outcomes.","volume":"39","year":"2016","journal-title":"Diabetes Care"},{"key":"R7-20260519","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S2213-8587(17)30104-3","article-title":"Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials.","volume":"5","author":"Zoungas","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"Suppl 1","key":"R8-20260519","first-page":"S158","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2024.","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"R9-20260519","doi-asserted-by":"crossref","first-page":"e181755","DOI":"10.1001\/jamanetworkopen.2018.1755","article-title":"Association of hemoglobin A1c levels with use of sulfonylureas, dipeptidyl peptidase 4 inhibitors, and thiazolidinediones in patients with type 2 diabetes treated with metformin: analysis from the observational health data sciences and informatics initiative.","volume":"1","author":"Vashisht","year":"2018","journal-title":"JAMA Network Open"},{"key":"R10-20260519","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1038\/s41598-024-52078-4","article-title":"Impact of metformin on cardiovascular and kidney outcome based on kidney function status in type 2 diabetic patients: a multicentric, retrospective cohort study.","volume":"14","author":"Yi","year":"2024","journal-title":"Sci Rep"},{"key":"R11-20260519","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4093\/dmj.2023.0128","article-title":"Two-year therapeutic efficacy and safety of initial triple combination of metformin, sitagliptin, and empagliflozin in drug-na\u00efve type 2 diabetes mellitus patients.","volume":"48","author":"Park","year":"2024","journal-title":"Diabetes Metab J"},{"key":"R12-20260519","doi-asserted-by":"crossref","first-page":"116117","DOI":"10.1016\/j.psychres.2024.116117","article-title":"Prenatal and infant exposure to antibiotics and subsequent risk of neuropsychiatric disorders in children: a nationwide birth cohort study in South Korea.","volume":"340","author":"Oh","year":"2024","journal-title":"Psychiatry Res"},{"key":"R13-20260519","doi-asserted-by":"crossref","first-page":"e077664","DOI":"10.1136\/bmj-2023-077664","article-title":"Prenatal opioid exposure and subsequent risk of neuropsychiatric disorders in children: nationwide birth cohort study in South Korea.","volume":"385","author":"Kang","year":"2024","journal-title":"BMJ"},{"key":"R14-20260519","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.2337\/dc21-1331","article-title":"The beneficial effects of earlier versus later implementation of intensive therapy in type 1 diabetes.","volume":"44","author":"Lachin","year":"2021","journal-title":"Diabetes Care"},{"key":"R15-20260519","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4239\/wjd.v6.i1.109","article-title":"\u03b2-cell dysfunction: its critical role in prevention and management of type 2 diabetes.","volume":"6","author":"Saisho","year":"2015","journal-title":"World J Diabetes"},{"key":"R16-20260519","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41392-024-01854-9","article-title":"Real-world effectiveness of early insulin therapy on the incidence of cardiovascular events in newly diagnosed type 2 diabetes.","volume":"9","author":"Luo","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"R17-20260519","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2337\/dc17-1144","article-title":"The legacy effect in type 2 diabetes: impact of early glycemic control on future complications (the diabetes & aging study).","volume":"42","author":"Laiteerapong","year":"2019","journal-title":"Diabetes Care"},{"key":"R18-20260519","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0140-6736(24)00537-3","article-title":"Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91).","volume":"404","author":"Adler","year":"2024","journal-title":"Lancet"},{"key":"R19-20260519","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41392-024-01755-x","article-title":"Metabolic memory: mechanisms and diseases.","volume":"9","author":"Dong","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"R20-20260519","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S2213-8587(13)70006-8","article-title":"Short-term intensive insulin therapy in type 2 diabetes mellitus: a systematic review and meta-analysis.","volume":"1","author":"Kramer","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R21-20260519","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/dom.13196","article-title":"Long-term effects on glycaemic control and \u03b2-cell preservation of early intensive treatment in patients with newly diagnosed type 2 diabetes: a multicentre randomized trial.","volume":"20","author":"Chon","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"R22-20260519","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00125-024-06254-w","article-title":"Glycaemic control is still central in the hierarchy of priorities in type 2 diabetes management.","volume":"68","author":"Khunti","year":"2025","journal-title":"Diabetologia"},{"key":"R23-20260519","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.","volume":"321","author":"Stratton","year":"2000","journal-title":"BMJ"},{"key":"R24-20260519","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa1800256","article-title":"Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes.","volume":"379","author":"Rawshani","year":"2018","journal-title":"N Engl J Med"},{"key":"R25-20260519","doi-asserted-by":"crossref","first-page":"e012356","DOI":"10.1161\/JAHA.119.012356","article-title":"Glycemic control, preexisting cardiovascular disease, and risk of major cardiovascular events in patients with type 2 diabetes mellitus: systematic review with meta-analysis of cardiovascular outcome trials and intensive glucose control trials.","volume":"8","author":"Giugliano","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"R26-20260519","doi-asserted-by":"crossref","first-page":"e142243","DOI":"10.1172\/JCI142243","article-title":"Pharmacological treatment of hyperglycemia in type 2 diabetes.","volume":"131","author":"Taylor","year":"2021","journal-title":"J Clin Invest"},{"key":"R27-20260519","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1111\/dom.15511","article-title":"Glycaemic control and macrovascular and microvascular outcomes: a systematic review and meta-analysis of trials investigating intensive glucose-lowering strategies in people with type 2 diabetes.","volume":"26","author":"Kunutsor","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"R28-20260519","doi-asserted-by":"crossref","first-page":"111814","DOI":"10.1016\/j.diabres.2024.111814","article-title":"\u03b2-cell function and long-term glycemic control in patients newly diagnosed with type 2 diabetes with moderate hyperglycemia after a 6-month course of basal insulin therapy.","volume":"215","author":"Kuo","year":"2024","journal-title":"Diabetes Res Clin Pract"},{"key":"R29-20260519","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/S0140-6736(08)60762-X","article-title":"Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial.","volume":"371","author":"Weng","year":"2008","journal-title":"Lancet"},{"key":"R30-20260519","doi-asserted-by":"crossref","first-page":"943","DOI":"10.3350\/cmh.2024.0203","article-title":"Long-term gastrointestinal and hepatobiliary outcomes of COVID-19: a multinational population-based cohort study from South Korea, Japan, and the UK.","volume":"30","author":"Lee","year":"2024","journal-title":"Clin Mol Hepatol"},{"key":"R31-20260519","doi-asserted-by":"crossref","first-page":"546","DOI":"10.4093\/dmj.2024.0249","article-title":"2023 clinical practice guidelines for diabetes management in Korea: full version recommendation of the Korean diabetes association.","volume":"48","author":"Moon","year":"2024","journal-title":"Diabetes Metab J"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047235","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T13:02:00Z","timestamp":1779195720000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047235","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"2025-09-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}